To assess the association of polymorphisms and haplotypes of the mineralocorticoid receptor (MR) (NR3C2) gene to the risk of essential hypertension (HTN) in a Spanish population.
Influence of genetic factors in the development of essential hypertension (HTN) has long been recognized. 1 Because it has a complex trait hereditary pattern, candidate gene strategies have been used to identify variations in genes, which can increase the susceptibility of being hypertensive. There are at least 150 candidate genes for essential HTN (http://cmbi.bjmu. edu.cn/genome/candidates/snps.html), and many of them play a major role in sodium handling. Likewise, the rare Mendelian forms of HTN involve key genes of sodium handling. Among them, a single mutation in the NR3C2 gene, S810L, causes early-onset HTN exacerbated during pregnancy. 2 The NR3C2 (Entrez gene ID: 4306), located on chromosome 4q31.1, consists of nine exons with a coding region spanning from exons 2-9. It produces a protein of 984 amino acids, 3, 4 which is a member of the nuclear receptor superfamily. It is expressed not only in the tubular cells of the kidney, but also in the heart and in both endothelial and vascular smooth muscle cells. 5, 6 The NR3C2 has an amino terminal region including a DNA-binding domain and a C-terminal region with the ligand-binding domain. 4 Aldosterone is the main ligand for the mineralocorticoid receptor (MR) in the kidney and in the cardiovascular system. 6, 7 In vitro studies demonstrated that a missense mutation rs41511344 (p.S810L) of the NR3C2 gene produces a gain of activity in the MR which is activated not only by aldosterone but also by cortisone, 11-β-dihydrocorticosterone, and progesterone. [8] [9] [10] [11] The receptor activation by these steroid hormones produces HTN in young women, which exacerbates during pregnancy. 2 This single mutation was not identified in large series of essential hypertensive subjects and seems to be that it does not play a role in essential HTN or in severe preeclampsia. 12, 13 Other nonsense/missense or frameshift mutations in the NR3C2 gene as c.2839C>T (p.R947X), c.1308T>A (p.C436X), c.1132_1133insT, c.315del8bp, c.1935C>A (p.C645X), c.1897G>A (p.G633R), c.2327A>G (p.Q776R), c.2936T>C (p.L979P), and c.488C>G (p.S163X) have been associated with pseudohypoaldosteronism type 1 due to loss of MR activity. 3, 4, [14] [15] [16] The mutation rs5522 (c.538A>G or p.I180V) have also been related with the response to mineralocorticoid treatment in patients with pseudohypoaldosteronism type 1 17, 18 and with the response to stress. 19 articles
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The potential impact of single-nucleotide polymorphism (SNP) of the NR3C2 gene on the risk of HTN, plasma-renin activity or serum aldosterone values, sodium urinary excretion, and on the response to thiazides has been tested with inconclusive results in a few number of studies. [20] [21] [22] [23] [24] [25] Wilk et al., by using genome-wide linkage analysis, showed that for early-onset HTN the maximum lod score was located in chromosome 4 overlying the NR3C2 gene locus in African Americans. 26 The fact that functional modifications in the sequence of NR3C2 gene can produce rare forms of monogenic HTN or hypotension makes to hypothesize whether or not common polymorphisms of the gene can result in susceptibility to essential HTN. The aim of this study was to evaluate the association of alleles and genotypes in 24 SNPs of the MR gene and its haplotypes with the blood pressure (BP) levels and therefore with the presence of essential HTN in a Spanish population. The possible interaction with sodium excretion was also analyzed. Furthermore, the presence of the rs41511344 (p.S810L) variant was investigated in the subset of young hypertensives.
Methods
Study design. This is a population-based study from general population of Spain. 27 Subjects >18 years old were randomly selected from the public register of the Western medical area of Valladolid (Spanish National Statistic Institute; http://ine.es). Subjects were invited to participate in the study by phone. Individuals with serious concomitant disease or psychiatric disorder were excluded. A second list of subjects was selected to replace those who rejected to take part in the study. The percentage of replacement was 32%. The calculated minimal sample size to be representative of the population was 1,400, from 1,504 individuals recruited. A more detailed description of the selection process has been previously described, which included a random sampling polystratified by all the relevant variables. 27 The study has been approved by the Ethical Committee and all the participants gave written agreement to participate.
Procedures. After inclusion, age and gender of each participant were registered along with a clinical record and a physical exam, which included height, weight, body mass index (BMI), and abdominal circumference. Information about individual and familiar cardiovascular risk factors as well as cardiovascular disease was collected. Spot urinary samples were collected for all the participants and stored at −85 °C. Venous blood samples were collected for analytical procedures and into tubes containing K3-EDTA to obtain genomic DNA. The estimated glomerular filtration rate (eGFR) was calculated by using the Cockcroft-Gault formula. 28 Sodium excretion. Twenty-four hour sodium excretion in mEq/ day was calculated from a spot sample of urine by the method developed by Tanaka and colleagues. 29, 30 Sodium and creatinine in urine were assessed by indirect potentiometry with selective electrode and Jaffé test, respectively. Both measures were performed in a Hitachi autoanalyzer (Roche diagnostics, Barcelona, Spain). Figure 1 .
DNA was isolated of peripheral blood cells using Realpure Genomic DNA extraction kit (Real Pure, Paterna, Spain) and samples were diluted to a final concentration of 100 ng/μl. Selected SNPs were genotyped using an oligo-ligation assay (SNPlex; Applied Biosystems, Foster City, CA) following the manufacturer's instructions.
The mutation S810L was genotyped in 147 hypertensive subjects <55 years old by amplification and sequenced in an ABI3730 system (Applied Biosystems). The direct PCRproducts were sequenced under standard conditions. The oligonucleotides used were forward gctaagtgtatttctgtgattaattgttttg and reverse tgaaagaaatcataacgcataactctg.
Statistical analysis.
All values are expressed as mean ± s.d. The χ 2 goodness-of-fit test was used to compare the distribution of the study population with the theoretical distribution of the reference population, which was estimated from the dates of the National Statistic Institute. Analysis of variance test was used to compare quantitative variates between groups and χ 2 -test for categorical variables using the software SPSS 12.0 for Windows (SPSS, Chicago, IL).
Genotype and alleles frequencies were calculated for every SNP. The best inheritance model was selected by the use of likelihood ratio test and the Akaike information criterion. The codominant model was used as the reference one. The HardyWeinberg equilibrium was sought by a χ 2 -distribution with one degree of freedom. Those SNPs that were not in HardyWeinberg equilibrium in the controls were excluded from the subsequent analysis. The Hardy-Weinberg equilibrium for every SNP was similar between the two different statistical packages used, HelixTree version 5.0 (Golden Helix, Bozeman, MT) and SNPStats developed by Sole and colleagues. 31 The association of HTN with each polymorphism was sought by articles Mineralocorticoid Receptor Gene in Hypertension logistic regression models adjusted by potential confounders. Age, BMI, and gender were used as covariates in all the models and the eGFR and the urinary sodium excretion were also included in subsequent models. A formal test for interaction between SNP and urinary sodium excretion was included by using SNPstats.
Haplotypes were designed using possible functional SNPs (3′-untranslated region (UTR) and 5′-UTR and nonsynonymous coding SNPs), tag-SNPs with an r 2 of ≥0.8 and according to the haploblocks. The D-statistic (defined as the LD measure, D, divided by the theoretical maximum for the observed allele frequencies) was used to measure the LD. Haplotypes frequencies were estimated by the expectation maximization algorithm. The association between haplotypes and HTN was analyzed by logistic regression and the expectation maximization algorithm was used to rebuild the haplotypes with the uncertain individuals so that they keep a different weight in the logistic regression model. The most frequent haplotype was selected as the reference one and we considered rare haplotypes those with a frequency <3%. Tag-SNPs, LD, and haploblocks were calculated using Haploview version 3.32. 32 Statistical power was calculated by means of the Power for Genetic Association software, developed by Menashe and colleagues 33 and using the results of the individual SNP analysis. The statistical power to detect significant differences for the SNP was >90% to detect an odds ratio (OR) >1.4 under codominant or dominant models, and for the haplotypes was >80% to detect an OR >1.5 under codominant and dominant model. Similar statistical power was obtained with the PAWE-3D (http://linkage.rockefeller.edu/pawe3d/) considering a 10% of errors due to genotype and phenotype misclassification under dominant or multiplicative models. 34, 35 Finally, we used the False Positive Report Probability (FPRP) 36 to consider a true association between polymorphisms and haplotypes with phenotype. This method takes into account the prior probability of every SNP, the observed P value and the desired statistical power. We have chosen to detect a statistical power of 0.8, inferior than the statistical power calculated and an OR of 1.5 (or its reciprocal, 0.67). A threshold of ≤0.5 for the FPRP was considered as a significant association.
results characteristics of the study population
The study population was finally 1,502, 49.7% women, mean age 52 years, 42.7% hypertensives and 7.6% diabetics. The main characteristics of the study population are shown in Table 1 . According to the BP criteria, 860 (57.2%) individuals were normotensives, 297 (19.7%) were hypertensive under treatment, and 345 (23.0%) were newly diagnosed of HTN. Hypertensive subjects, compared with nonhypertensive, were aged and had significantly higher values of weight, BMI, and waist diameter. They also had higher levels of fasting glucose, plasma creatinine, triglycerides, total cholesterol, and low-density lipoprotein. Hypertensive patients under treatment were older E9   rs2871  rs10032250  rs1879829  rs1403142  rs1040288  rs2272089  rs7668847  rs11099680  rs13116332  rs11724292  rs12498662  rs10519952  rs6535598  rs1512337  rs13117325  rs2137335  rs17024654  rs10434100  rs6849903  rs1996025 articles
Mineralocorticoid Receptor Gene in Hypertension
and had significantly lower levels of systolic BP, diastolic BP, eGFR, and urinary sodium excretion than normotensive subjects and hypertensive individuals in the absence of treatment. Likewise, hypertensive patients under treatment had significantly lower levels of eGFR and urinary sodium excretion as compared to normotensive subjects.
snPs, blood pressure, and htn risk
The following SNPs were excluded from the analysis because they were not in Hardy-Weinberg equilibrium: rs10032250 (c.2800−15793C>T), rs2248038 (c.−6987A>G), rs6849903 (c.1757+57210T>G), and rs10434100 (c.1757+68449C>T). Among the remaining SNPs studied, only alleles of the SNP rs5522 were significantly associated with the risk of HTN, both in the recessive and codominant models after adjusting by age, gender, and BMI and also when urinary sodium excretion and eGFR were added to the models (see Tables 2, 3 , and 4). In the first step, we selected six polymorphisms containing 3′-UTR and 5′-UTR SNPs, functional mutation rs5522, and tag-SNPs, being the final haplotype formed by alleles of the following SNPs: rs2871, rs1040288, rs10519952, rs1512337, rs5522, and rs2070951. Four of the haplotypes were associated with risk of HTN as compared to the most frequent haplotype, AGTAAG, adjusted by age, gender, and BMI (see Table 2 ).
In a second step, we reduced the number of polymorphisms to three SNPs: rs10519952, rs1512337, and rs5522. Haplotype 5 was protective against the development of HTN (P < 0.05). This haplotype included the allele G of rs5522 and alleles T and G of the tag-SNPs, which were in LD with rs10519952 and rs1512337 (r 2 > 0.8).
The results of FPRP for the association between polymorphism rs5522 and haplotypes with the risk of HTN are shown in Table 2 . The FPRP excluded that significant association between the rs5522 and the haplotypes and the risk for HTN were by chance.
relationship with sodium excretion
The mean of urinary sodium excretion was 131 ± 62 mEq/day. The sodium excretion in each genotype of the rs5522 was no different (AA 130 mEq/day, AG 131 mEq/day, GG 129 mEq/ day; P = 0.97). When the estimated 24-h sodium excretion was included in the logistic regression model, the degree of association for the rs5522 polymorphism and for the haplotypes did not change ( Table 3) . A significant interaction between genotypes of the rs5522 and quartiles of 24-h sodium excretion was observed (P < 0.05). In subjects with the AA genotype, those with higher urinary sodium excretion had the lowest risk to be hypertensive (Supplementary Table S2 online). Likewise, the addition of the eGFR to the logistic regression model did not change the degree of association either in the absence (data not shown) or in the presence of urinary sodium excretion ( Table 4 ). The data corresponding to the full logistic regression model are shown in Supplementary Table S3 online.
assessment of the s810l mutation
We also investigated the presence of the functional mutation rs41511344 (p.S810L) in the hypertensive subjects <55 years old. No subjects carried the p.S810L among the 147 individuals tested.
discussion
In a general population of Caucasian subjects, the genotype GG of the rs5522 was significantly associated with lower risk of HTN after adjusted by potential confounders. The haplotypes containing the A allele of the rs5522 were also significantly related to an increased risk of HTN and one haplotype that included the G allele resulted protective. The associations remained when the sodium excretion and the eGFR were considered. articles
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The rs5522 polymorphism, also named c.538A>G, produces a missense mutation changing isoleucine to valine at codon 180 (p.I180V), which has influence on the MR activity. The response to increasing aldosterone concentrations was lower for the homozygote genotype as compared to the wild type, 18 although other authors found a mild loss of function when cortisol was the ligand instead of aldosterone. 19 Besides the experimental data supporting the functionality of the polymorphism, several clinical studies have tried to relate the rs5522 polymorphism with the responsiveness to stress and with sodium-handling abnormalities. In a German cohort of twins, 19 allele G carriers had higher levels of salivary and plasma cortisol but not adrenocorticotropic hormone and higher heart rate response to the Trier Social Stress Tests. The authors suggested that taking into account the N-terminal position of the rs5522 in the exon 2, the amino acid valine instead of isoleucin at the position 180 of the MR protein could affect the binding of specific cofactors, rather than the ligand binding itself, and that this variant can be more important in the response to stress than for sodium handling. 19 Previous studies did not find a relationship between the polymorphism rs5522 and HTN risk or aldosterone levels. In the offspring study of the Framingham cohort, which included 2,891 individuals, no relationship between genotypes of the articles Mineralocorticoid Receptor Gene in Hypertension rs5522 and serum aldosterone was found and a low heritability rate (0.10) for serum aldosterone was reported. 24 In hypertensive subjects, who underwent the Weinberger's test to assess salt-sensitivity, no significant differences in urinary sodium excretion, plasma aldosterone, and plasma-renin activity among genotypes were found. Likewise, there were no differences for salt sensitive or salt resistant between carriers and noncarriers of the variant allele. 19 Moreover, no relationship between the rs5522 and the BP lowering effect of thiazide was observed. 20 In this study, which included 24 SNPs along the entire gene, only the rs5522 was associated with the risk of HTN, but haplotypes carrying both the protective and the risky alleles were significantly associated with HTN. The fact that some mutations in the gene NR3C2 can be related to the risk of HTN, and others with their protection, makes this gene a potential candidate gene for HTN. Considering the functional characteristics of the rs5522 of the MR gene, we hypothesize that the allele G of the rs5522, when it is in homozygosis, could modify the MR function and could produce salt waste and consequently protect from blood pressure elevation. Carriers of the wild type, however, would have greater susceptibility of HTN in combination with other alleles in different positions forming haplotypes of risk. Nowadays, it is thought that it would be the combination of variants of slight risk what would produce the genetic susceptibility in complex inheritance diseases altogether with environmental factors. It could be inferred that this functional SNP and the haplotypes described above might produce different responses to salt intake. Even though the inclusion of 24-h sodium excretion did not modify the associations observed, an interaction between genotype and sodium excretion was observed.
The interaction between urinary sodium excretion and the polymorphism rs5522 on the risk of HTN indicated that among the subjects with the AA genotype those who excreted more sodium had a lowest risk to be hypertensive. This apparent contradiction to the main results of the study, in which the presence of the G allele resulted protective, can be explained by the fact that the AA subjects as a group had more risk to develop HTN but those able to excrete more sodium had the lowest risk as compared to those who excreted less sodium in the urine.
Limitations of this study were the absence of data about plasma renin-aldosterone profile and the absence of a functional study of the haplotypes related to both the high risk and the protection to develop HTN. On the other hand, one of the major strengths of this study is that we have considered the sodium excretion, as well as the eGFR, as a possible factor of interaction between this gene and blood pressure levels and with the risk of HTN. Moreover, population was selected as representative of a Spanish region with a very low immigration rate.
Other strength of the study was our levels of statistical power >90% to detect low OR in a genetic association study even when considering a 10% of phenotype and genotype misclassification errors. The use of the FPRP to assess the association also reinforces our results. This last test was defined as:
, where α is the probability of a statistically significant finding given that null hypothesis of no association is true; 1 − β is the statistical power, and π is the prior probability to assess the probability of a no true association. [37] [38] [39] [40] [41] [42] The observed values of the FPRP in the noteworthy category, ranging from 8 to 46%, with a low prior association of 0.01 supported the association.
In summary, the data provided in this study seems to give credit to the hypothesis of the participation of MR gene in the development of HTN, although further studies are necessary to better assess its potential role.
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